弁理士試験の合格者データ - 弁理士試験対策講座|資格の予備校ならLEC東京リーガルマインド,Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged ≥65 years from the PAOLA-1/ENGOT-ov25 trial - European Journal of Cancer,Efficacy and safety of maintenance olaparib and bevacizumab in ovarian cancer patients aged ≥65 years from the PAOLA-1/ENGOT-ov25 trial - European Journal of Cancer,学术活动】哥伦比亚大学顾雨琦助理教授学术报告- 清华大学统计学研究中心,PAOLA-1 Phase 3 Trial – Efficacy of LYNPARZA® (olaparib) + Bevacizumab for Advanced Ovarian Cancer